MARLOWE ranked microbial contributors well in controlled tests, but its results were less reliable for secondary sources and less specific than MiCId in the broader comparison.
A systematic review of GLP-1 and dual GIP/GLP-1 drugs found no consistent signal of psychiatric harm, but said the evidence is too mixed to determine whether most reported outcomes are treatment-related.